PSYCHOLOGICAL ASPECTS OF VISUAL ACUTY DYSFUNCTION IN CENTRAL RETINAL VEIN OCCULSION (OVCR/ CRVO)
Keywords:
central retinal vein occlusion, macular edema, neovascularization, secondary glaucoma, non-ischemic and ischemic CRVO, psychological disordersAbstract
Central retinal vein occlusion (CRVO) is a significant vascular disorder that leads to sudden reduction of visual acuity and serious functional visual impairment in affected patients. The occlusion may occur at the level of the central retinal vein or its branches. Etiologically, it most commonly affects the elderly population and is associated with risk factors such as arterial hypertension, diabetes mellitus, hyperlipidemia, and increased intraocular pressure. Clinically, CRVO is classified into non-ischemic form and ischemic forms. The non-ischemic form is characterized by milder symptomatology and better prognosis, while the ischemic form is accompanied by a more severe clinical picture, with the appearance of macular edema, neovascularization and risk of secondary glaucoma. The decrease in visual acuity significantly affects the guality of life of sufferers, and is often accompanied by psychological disorders, such as shock and disbelief, anxiety, depression, anger and frustration, fear of blindness, decreased self-esteem, and a general decline in the quality of life. Timely diagnosis appropriate ophthalmological treatment, and a multidisciplinary approach, including psychological support, play a key role in improving the visual function and psychosocial status of patients with CRVO.
References
Boagey, H., Jolly, J. K., & Ferrey, A. E. (2022). Psychological impact of vision loss. Eye, 36, 1800-1808.
BMJ Best Practice. (2026). Retinal vein occlusion: Symptoms, diagnosis and treatment. BMJ Publishing Group.
Christensen, V.R., Rugaard, C., Sorensen, T. L., & Larsen, M. (2026). A systematic review of eligibility criteria in randomized controlled trials of anti-VEGF therapy for retinal vein occlusion. Ophthalmology and Therapy Advance online publication.
Darabus, D. M., Dǎrǎbus, R. G., & Munteanu, M. (2025). The diagnosis and treatment of branch retinal vein occlusion. Biomedicines, 13(1), 105.
Gazepov, S. (2025). Slabovidnost. Univerzitet ,,Goce Delcev’’-Shtip
Gazepov, S. (2019). Oftalmoloski I opticki instrumenti. Univerzitet ,,Goce Delcev’’ – Stip.
Guceva N.L. (2020). Oftalmologija. Univerzitet ,,Goce Delcev’’ – Stip.
Karabulut, E., Yilmaz, S., Arslan, B., & Demir, G. (2024). Factors affecting quality of life and hopelessness in patients receiving intravitreal injection. Klinik Psikofarmakoloji Bulteni.
Kyle Blair & Craing N. Czyz. (2025). Central retinal vein occlusion. In StatPearls. StatPearls Publishing
Janev , K. (2012). Opsta oftalmologija – treto izdanie Skopje.
Lang, G.K., (2016) Ophthalmology 3 rd Edition
Lee, J. – Y., Wang, S.-M., Jeon, S.-H., Kim, M.-H., Han, K.-D., & Roh, Y.-J. (2023). The risk of retinal vein occlusion in young patients with mental disordes: A nationwide cohort study. Journal of Clinical Medicine, 12(14), 4874.
Mehta, S. (2024). Central retinal vein occlusion and branch retinal vein occlusion. In MSD Manual Professional Edition.
Salmon, J. F. (2024). Kanski’s Clinical Ophthalmology: A systematic approach (10th ed.). Elsevier.
The ALBATROS Study Group: Korobelnik, J.-F., Holz, F. G., Roider, J., Ogura, Y., Simader, C., & Schmidt-Erfurth, U. (2023). The psychological, social, and behavioral impact of intravitreal anti-VEGF therapy: An analysis from the ALBATROS data. Ophthalmology and Therapy.
